Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2024-12-06 00:00:00 ET · period of report 2024-12-04 · accession 0001873919-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-06 | 2024-12-04+ | CADL | Aguilar Laura K. | 10% | D - Sale to Iss | $4.83 | -60.0K | 111.3K | -35% | -$289.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2024-12-04 | D | D | 20,000 | $4.46 | 131,335 | D | — | — | (F1) Shares of common stock held jointly with spouse |
| 2 | Common | CADL | 2024-12-06 | D | D | 20,000 | $5.23 | 91,335 | D | — | — | (F1) Shares of common stock held jointly with spouse |
| 3 | Common | CADL | 2024-12-05 | D | D | 20,000 | $4.79 | 111,335 | D | — | — | (F1) Shares of common stock held jointly with spouse |